Royal Bank of Canada’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,185
| Closed | – | – | 7567 |
|
|
2022
Q3 | $0 | Buy |
2,185
+185
| +9% | – | ﹤0.01% | 7599 |
|
|
2022
Q2 | $1K | Hold |
2,000
| – | – | ﹤0.01% | 6823 |
|
|
2022
Q1 | $3K | Hold |
2,000
| – | – | ﹤0.01% | 6944 |
|
|
2021
Q4 | $5K | Hold |
2,000
| – | – | ﹤0.01% | 6714 |
|
|
2021
Q3 | $6K | Sell |
2,000
-956
| -32% | -$2.87K | ﹤0.01% | 6582 |
|
|
2021
Q2 | $11K | Sell |
2,956
-479
| -14% | -$1.78K | ﹤0.01% | 6349 |
|
|
2021
Q1 | $12K | Buy |
3,435
+211
| +7% | +$737 | ﹤0.01% | 6238 |
|
|
2020
Q4 | $11K | Buy |
3,224
+1,201
| +59% | +$4.1K | ﹤0.01% | 5795 |
|
|
2020
Q3 | $7K | Sell |
2,023
-108
| -5% | -$374 | ﹤0.01% | 5572 |
|
|
2020
Q2 | $10K | Buy |
+2,131
| New | +$10K | ﹤0.01% | 5371 |
|
|
2020
Q1 | – | Sell |
-2,921
| Closed | -$18K | – | 6437 |
|
|
2019
Q4 | $18K | Buy |
+2,921
| New | +$18K | ﹤0.01% | 5314 |
|
|
2019
Q3 | – | Sell |
-7
| Closed | – | – | 6286 |
|
|
2019
Q2 | $0 | Buy |
+7
| New | – | ﹤0.01% | 6113 |
|